| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.24 | 0.0002 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.0003 |